We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
CDV3 is not prognostic in Ovary Serous Cystadenocarcinoma (TCGA)
Stage:
Survival analysis
Current cut offi
Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.
:
Best expression cut offi
Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .
When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.
Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.
Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.
: N/A
P scorei
Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.
N/A
5-year survival highi
5-year survival for patients with higher expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
5-year survival lowi
5-year survival for patients with lower expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
TCGA RNA samplesi
RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .
Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.
Average TPM
54.7
Number of samples
349
Samples
Sample
Description
TPM
TCGA-24-1474-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 676 days
158.4
TCGA-29-A5NZ-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1088 days
131.1
TCGA-23-1809-01A
0 years, female, white, stage:Stage IIC, alive, 16 days
120.1
TCGA-25-1633-01A
0 years, female, white, stage:Stage IIIC, dead, 1891 days
115.0
TCGA-24-2254-01A
0 years, female, white, stage:Stage IIIC, dead, 1736 days
114.8
TCGA-61-2111-01A
0 years, female, white, stage:Stage IV, alive, 3825 days
112.8
TCGA-24-1567-01A
0 years, female, white, stage:Stage IIIB, dead, 524 days
110.6
TCGA-24-1928-01A
0 years, female, white, stage:Stage IIIC, dead, 336 days
109.7
TCGA-25-1628-01A
0 years, female, white, stage:Stage IIIC, dead, 627 days
109.6
TCGA-61-2098-01A
0 years, female, white, stage:Stage IIIC, alive, 1993 days
109.2
TCGA-24-2027-01A
0 years, female, white, stage:Stage IV, dead, 3337 days
107.9
TCGA-24-2288-01A
0 years, female, white, stage:Stage IIIC, dead, 25 days
107.8
TCGA-24-1434-01A
0 years, female, white, stage:Stage IIIC, dead, 568 days
107.4
TCGA-31-1953-01A
0 years, female, asian, stage:Stage IIIC, alive, 204 days
107.3
TCGA-31-1951-01A
0 years, female, white, stage:Stage IIIC, alive, 684 days
105.5
TCGA-25-2042-01A
0 years, female, american indian or alaska native, stage:Stage IIIC, dead, 396 days
105.5
TCGA-61-1737-01A
0 years, female, white, stage:Stage IV, alive, 1364 days
105.4
TCGA-57-1994-01A
0 years, female, white, stage:'--, alive, 761 days
103.5
TCGA-09-0364-01A
0 years, female, white, stage:Stage IIC, dead, 887 days
102.8
TCGA-24-1549-01A
0 years, female, white, stage:Stage IIIB, dead, 1721 days
99.2
TCGA-5X-AA5U-01A
0 years, female, black or african american, stage:Stage IIC, alive, 361 days
98.5
TCGA-13-1511-01A
0 years, female, asian, stage:Stage IV, dead, 1650 days
97.3
TCGA-24-2289-01A
0 years, female, white, stage:Stage IV, dead, 2049 days
96.0
TCGA-24-1846-01A
0 years, female, stage:Stage IIIC, alive, 133 days
93.6
TCGA-25-1627-01A
0 years, female, white, stage:Stage IIIC, dead, 394 days
92.6
TCGA-24-1550-01A
0 years, female, white, stage:Stage IIIC, dead, 1249 days
91.6
TCGA-61-1733-01A
0 years, female, white, stage:Stage IIIC, alive, 967 days
91.4
TCGA-25-1626-01A
0 years, female, white, stage:Stage IIIC, dead, 518 days
91.1
TCGA-24-1417-01A
0 years, female, white, stage:Stage IV, alive, 238 days
91.1
TCGA-24-1558-01A
0 years, female, white, stage:Stage IIIC, dead, 594 days
91.0
TCGA-61-2003-01A
0 years, female, white, stage:Stage IIIC, alive, 122 days
90.9
TCGA-25-1320-01A
0 years, female, white, stage:Stage IIIC, dead, 1155 days
90.6
TCGA-61-1900-01A
0 years, female, black or african american, stage:Stage IIIB, alive, 176 days
90.6
TCGA-36-1581-01A
0 years, female, white, stage:Stage IIC, alive, 751 days
90.5
TCGA-61-2113-01A
0 years, female, white, stage:Stage IIC, dead, 676 days
90.2
TCGA-25-2400-01A
0 years, female, white, stage:Stage IIIC, dead, 1278 days
90.0
TCGA-59-2350-01A
0 years, female, stage:Stage IV, dead, 679 days
88.3
TCGA-24-2261-01A
0 years, female, white, stage:Stage IIIC, dead, 24 days
88.2
TCGA-59-A5PD-01A
0 years, female, black or african american, stage:Stage IC, dead, 624 days
88.0
TCGA-23-2078-01A
0 years, female, white, stage:Stage IIIC, alive, 2661 days
87.8
TCGA-24-2293-01A
0 years, female, white, stage:'--, dead, 506 days
87.2
TCGA-25-1623-01A
0 years, female, white, stage:Stage IV, dead, 565 days
86.6
TCGA-61-1995-01A
0 years, female, white, stage:Stage IIIC, alive, 61 days
86.2
TCGA-61-2102-01A
0 years, female, white, stage:Stage IIIC, dead, 197 days
85.3
TCGA-25-1318-01A
0 years, female, white, stage:Stage IIIC, dead, 1064 days
85.1
TCGA-24-1842-01A
0 years, female, white, stage:Stage IIIC, alive, 253 days
84.8
TCGA-36-1569-01A
0 years, female, white, stage:Stage IIIC, alive, 885 days
83.8
TCGA-24-1424-01A
0 years, female, white, stage:Stage IIIC, alive, 183 days
83.7
TCGA-24-1418-01A
0 years, female, white, stage:Stage IIIC, alive, 243 days
83.6
TCGA-61-2104-01A
0 years, female, white, stage:Stage IIC, alive, 2338 days
82.4
TCGA-61-2097-01A
0 years, female, white, stage:Stage IIC, alive, 1844 days
82.0
TCGA-OY-A56Q-01A
0 years, female, black or african american, stage:Stage IIA, alive, 576 days
81.2
TCGA-29-1710-01A
0 years, female, white, stage:Stage IIIC, dead, 951 days
81.0
TCGA-61-2002-01A
0 years, female, white, stage:Stage IIIC, alive, 547 days
80.3
TCGA-24-1616-01A
0 years, female, white, stage:Stage IIIC, dead, 1163 days
79.0
TCGA-25-1630-01A
0 years, female, white, stage:Stage IIIC, dead, 1162 days
78.9
TCGA-36-1576-01A
0 years, female, stage:Stage IIIC, alive, 915 days
78.8
TCGA-25-2399-01A
0 years, female, white, stage:Stage IIIC, dead, 608 days
78.6
TCGA-09-2054-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 637 days
78.2
TCGA-25-1870-01A
0 years, female, white, stage:Stage IIIC, dead, 455 days
77.7
TCGA-25-1323-01A
0 years, female, white, stage:Stage IIIC, dead, 395 days
76.9
TCGA-04-1362-01A
0 years, female, white, stage:Stage IIC, dead, 1348 days
76.7
TCGA-24-2290-01A
0 years, female, white, stage:Stage IIIC, dead, 1102 days
75.6
TCGA-31-1946-01A
0 years, female, stage:Stage IIIC, alive, 918 days
75.0
TCGA-13-1495-01A
0 years, female, white, stage:Stage IIIC, dead, 2749 days
74.9
TCGA-24-1427-01A
0 years, female, stage:Stage IIIC, alive, 147 days
74.8
TCGA-24-2267-01A
0 years, female, white, stage:Stage IIB, dead, 1446 days
74.8
TCGA-24-2020-01A
0 years, female, white, stage:Stage IIIC, dead, 4624 days
74.7
TCGA-61-2000-01A
0 years, female, white, stage:Stage IIIC, alive, 441 days
73.9
TCGA-23-1120-01A
0 years, female, white, stage:Stage IIIC, alive, 130 days
73.6
TCGA-25-1312-01A
0 years, female, white, stage:Stage IV, dead, 31 days
73.4
TCGA-24-1422-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 23 days
73.3
TCGA-57-1585-01A
0 years, female, white, stage:Stage IIIC, dead, 53 days
73.3
TCGA-25-2398-01A
0 years, female, white, stage:Stage IIIC, dead, 1369 days
73.2
TCGA-13-A5FT-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 2143 days
72.8
TCGA-20-1682-01A
0 years, female, white, stage:Stage IIIC, alive, 837 days
72.5
TCGA-57-1993-01A
0 years, female, white, stage:Stage IIIC, alive, 763 days
72.4
TCGA-09-2051-01A
0 years, female, white, stage:Stage IIIC, alive, 1919 days
72.3
TCGA-61-2009-01A
0 years, female, white, stage:Stage IIIC, alive, 1212 days
72.2
TCGA-24-1603-01A
0 years, female, white, stage:Stage IIIB, dead, 2742 days
71.7
TCGA-04-1514-01A
0 years, female, white, stage:Stage IIIA, dead, 1720 days
71.3
TCGA-29-1705-01A
0 years, female, white, stage:Stage IIIC, dead, 555 days
71.1
TCGA-09-1670-01A
0 years, female, white, stage:Stage IIIA, alive, 547 days
71.1
TCGA-24-1551-01A
0 years, female, white, stage:Stage IIIC, dead, 1579 days
70.9
TCGA-13-0883-01A
0 years, female, white, stage:Stage IIIC, dead, 2097 days
70.6
TCGA-61-2109-01A
0 years, female, white, stage:Stage IIIC, dead, 629 days
70.5
TCGA-59-2363-01A
0 years, female, asian, stage:Stage IIIA, alive, 165 days
70.3
TCGA-25-2404-01A
0 years, female, american indian or alaska native, stage:Stage IIIC, dead, 883 days
69.8
TCGA-23-2084-01A
0 years, female, white, stage:Stage IV, dead, 1516 days
69.7
TCGA-24-1425-01A
0 years, female, white, stage:Stage IIIC, alive, 181 days
69.4
TCGA-25-1326-01A
0 years, female, white, stage:Stage IIIC, dead, 1249 days
68.2
TCGA-04-1530-01A
0 years, female, white, stage:Stage IIIC, dead, 3622 days
68.2
TCGA-31-1959-01A
0 years, female, white, stage:Stage IV, alive, 67 days
68.0
TCGA-24-1847-01A
0 years, female, white, stage:Stage IV, alive, 343 days
67.9
TCGA-24-1604-01A
0 years, female, white, stage:Stage IIIC, dead, 2688 days
67.6
TCGA-24-2280-01A
0 years, female, white, stage:Stage IIIC, alive, 2143 days
67.3
TCGA-31-1950-01A
0 years, female, white, stage:Stage IIIC, alive, 571 days
67.3
TCGA-36-1580-01A
0 years, female, stage:Stage IIIC, dead, 737 days
67.1
TCGA-23-2077-01A
0 years, female, white, stage:Stage IIIC, alive, 3525 days
66.8
TCGA-25-1322-01A
0 years, female, white, stage:Stage IV, dead, 91 days
66.7
TCGA-36-1571-01A
0 years, female, white, stage:Stage IIIB, dead, 695 days
66.6
TCGA-20-1683-01A
0 years, female, white, stage:Stage IIIC, alive, 772 days
66.6
TCGA-VG-A8LO-01A
0 years, female, black or african american, stage:Stage IV, dead, 24 days
66.1
TCGA-13-1405-01A
0 years, female, white, stage:Stage IV, dead, 868 days
66.0
TCGA-WR-A838-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 304 days
65.9
TCGA-13-1410-01A
0 years, female, white, stage:Stage IV, alive, 2464 days
65.8
TCGA-59-2354-01A
0 years, female, white, stage:Stage IIIC, dead, 1046 days
65.3
TCGA-24-2033-01A
0 years, female, white, stage:Stage IIIC, dead, 562 days
65.3
TCGA-24-1930-01A
0 years, female, white, stage:Stage IIIC, dead, 2467 days
65.0
TCGA-25-1631-01A
0 years, female, white, stage:Stage IIIC, dead, 9 days
64.8
TCGA-23-1028-01A
0 years, female, white, stage:Stage IIIC, alive, 1503 days
64.6
TCGA-31-1944-01A
0 years, female, white, stage:Stage IIIC, alive, 1386 days
64.6
TCGA-25-2401-01A
0 years, female, white, stage:Stage IIIC, dead, 90 days
64.3
TCGA-57-1586-01A
0 years, female, white, stage:Stage IIIC, alive, 679 days
64.3
TCGA-24-1435-01A
0 years, female, white, stage:Stage IIIC, dead, 1324 days
64.0
TCGA-24-1423-01A
0 years, female, white, stage:Stage IIIC, alive, 190 days
63.9
TCGA-24-1467-01A
0 years, female, white, stage:Stage IIIC, dead, 3224 days
63.8
TCGA-25-1319-01A
0 years, female, white, stage:Stage IIIC, dead, 1977 days
63.6
TCGA-09-1673-01A
0 years, female, white, stage:Stage IV, alive, 92 days
63.5
TCGA-04-1365-01A
0 years, female, white, stage:Stage IIIB, alive, 947 days
63.5
TCGA-61-1741-01A
0 years, female, white, stage:Stage IIIB, dead, 1024 days
63.0
TCGA-23-1123-01A
0 years, female, white, stage:Stage IIIC, dead, 1018 days
63.0
TCGA-59-2351-01A
0 years, female, white, stage:Stage IIIC, alive, 3532 days
63.0
TCGA-25-1315-01A
0 years, female, white, stage:Stage IIIC, dead, 1583 days
62.5
TCGA-36-1574-01A
0 years, female, asian, stage:Stage IIIC, alive, 686 days
62.2
TCGA-13-1411-01A
0 years, female, white, stage:Stage IIIC, dead, 531 days
62.2
TCGA-13-1506-01A
0 years, female, white, stage:Stage IIIC, dead, 1039 days
62.0
TCGA-10-0928-01A
0 years, female, white, stage:Stage IIIC, dead, 563 days
61.9
TCGA-29-1770-01A
0 years, female, white, stage:Stage IIIC, alive, 741 days
61.7
TCGA-59-2352-01A
0 years, female, white, stage:Stage IIIC, dead, 286 days
60.9
TCGA-29-1711-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 1053 days
60.9
TCGA-25-1634-01A
0 years, female, white, stage:Stage IIIC, dead, 1091 days
60.6
TCGA-61-2008-01A
0 years, female, asian, stage:Stage IIC, alive, 932 days
59.4
TCGA-13-1403-01A
0 years, female, white, stage:Stage IIIC, dead, 2345 days
59.4
TCGA-24-2026-01A
0 years, female, white, stage:Stage IIIC, dead, 1059 days
59.0
TCGA-25-1329-01A
0 years, female, white, stage:Stage IIIC, dead, 457 days
58.6
TCGA-25-2393-01A
0 years, female, white, stage:Stage IIIC, dead, 1157 days
58.6
TCGA-09-1662-01A
0 years, female, white, stage:Stage IV, dead, 2717 days
58.5
TCGA-25-1632-01A
0 years, female, white, stage:Stage IV, dead, 1799 days
58.2
TCGA-30-1861-01A
0 years, female, white, stage:Stage IIIC, dead, 1058 days
57.9
TCGA-23-1122-01A
0 years, female, white, stage:Stage IIIC, dead, 1189 days
57.7
TCGA-13-0906-01A
0 years, female, white, stage:Stage IIIC, alive, 3619 days
57.6
TCGA-59-2348-01A
0 years, female, white, stage:Stage IIIC, alive, 5481 days
57.4
TCGA-24-1413-01A
0 years, female, white, stage:Stage IIIC, alive, 192 days
57.3
TCGA-29-1703-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1815 days
57.3
TCGA-25-1328-01A
0 years, female, white, stage:Stage IIIC, dead, 2009 days
57.2
TCGA-25-1635-01A
0 years, female, white, stage:Stage IIIC, dead, 1583 days
56.9
TCGA-09-0366-01A
0 years, female, white, stage:Stage IIIC, dead, 1757 days
56.9
TCGA-24-1426-01A
0 years, female, white, stage:Stage IIIC, alive, 163 days
56.9
TCGA-61-1918-01A
0 years, female, white, stage:Stage IV, dead, 479 days
56.7
TCGA-13-0916-01A
0 years, female, white, stage:Stage IIIC, alive, 1785 days
56.6
TCGA-29-1762-01A
0 years, female, white, stage:Stage IV, dead, 2634 days
56.6
TCGA-13-0924-01A
0 years, female, white, stage:Stage IV, alive, 2614 days
56.0
TCGA-57-1584-01A
0 years, female, white, stage:Stage IIIC, alive, 643 days
55.5
TCGA-24-1560-01A
0 years, female, white, stage:Stage IIIC, dead, 1341 days
55.4
TCGA-24-2024-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1769 days
55.3
TCGA-10-0933-01A
0 years, female, white, stage:Stage IIIC, dead, 446 days
54.9
TCGA-30-1891-01A
0 years, female, white, stage:Stage IIIC, dead, 914 days
54.8
TCGA-24-1563-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1451 days
54.7
TCGA-61-2012-01A
0 years, female, white, stage:Stage IIC, alive, 932 days
54.5
TCGA-25-1317-01A
0 years, female, white, stage:Stage IIIC, dead, 61 days
54.3
TCGA-13-0886-01A
0 years, female, white, stage:Stage IIIC, alive, 4665 days
54.3
TCGA-29-1697-01A
0 years, female, white, stage:Stage IIIC, dead, 949 days
54.2
TCGA-25-2392-01A
0 years, female, white, stage:Stage IV, dead, 31 days
54.0
TCGA-61-1998-01A
0 years, female, white, stage:Stage IIIC, alive, 168 days
53.7
TCGA-24-2298-01A
0 years, female, white, stage:Stage IIIC, dead, 1620 days
53.7
TCGA-24-1562-01A
0 years, female, white, stage:Stage IIIC, dead, 1384 days
53.4
TCGA-29-1778-01A
0 years, female, white, stage:Stage IIIC, alive, 454 days
52.8
TCGA-13-0800-01A
0 years, female, white, stage:Stage IIIC, alive, 2661 days
52.7
TCGA-29-1688-01A
0 years, female, white, stage:Stage IIIC, dead, 2400 days
52.6
TCGA-61-1907-01A
0 years, female, white, stage:Stage IIIC, alive, 952 days
52.4
TCGA-57-1582-01A
0 years, female, white, stage:Stage IIIC, dead, 731 days
52.3
TCGA-31-1956-01A
0 years, female, white, stage:Stage IIIB, alive, 1342 days
52.2
TCGA-13-1487-01A
0 years, female, white, stage:Stage IV, dead, 681 days
52.0
TCGA-29-2425-01A
0 years, female, white, stage:Stage IIIC, alive, 1977 days
51.9
TCGA-24-2023-01A
0 years, female, white, stage:Stage IIIA, dead, 1364 days
51.9
TCGA-09-1666-01A
0 years, female, white, stage:Stage IIIC, alive, 1752 days
51.7
TCGA-13-0768-01A
0 years, female, white, stage:Stage IIIC, dead, 1784 days
51.6
TCGA-04-1331-01A
0 years, female, white, stage:Stage IIIC, dead, 1336 days
51.3
TCGA-29-1694-01A
0 years, female, white, stage:Stage IIIC, dead, 1187 days
51.2
TCGA-13-0797-01A
0 years, female, white, stage:Stage IIIC, alive, 2121 days
51.0
TCGA-13-1510-01A
0 years, female, white, stage:Stage IIIC, dead, 1359 days
50.9
TCGA-24-1469-01A
0 years, female, white, stage:Stage IIIC, alive, 277 days
50.5
TCGA-13-1483-01A
0 years, female, white, stage:Stage IIIC, dead, 895 days
50.4
TCGA-25-1321-01A
0 years, female, white, stage:Stage IIIC, dead, 1033 days
50.0
TCGA-29-1776-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 360 days
49.7
TCGA-24-0968-01A
0 years, female, white, stage:Stage IIIC, dead, 598 days
49.6
TCGA-25-2396-01A
0 years, female, white, stage:Stage IIIC, dead, 92 days
49.6
TCGA-24-1105-01A
0 years, female, white, stage:Stage IIIC, dead, 1442 days
49.5
TCGA-24-1419-01A
0 years, female, white, stage:Stage IIIC, alive, 239 days
49.4
TCGA-29-1783-01A
0 years, female, white, stage:Stage IIIC, alive, 220 days
49.1
TCGA-29-2428-01A
0 years, female, white, stage:Stage IIIC, alive, 1372 days
48.9
TCGA-36-1570-01A
0 years, female, white, stage:Stage IIIC, alive, 655 days
48.6
TCGA-24-2036-01A
0 years, female, white, stage:Stage IIIA, dead, 1947 days
48.6
TCGA-29-1695-01A
0 years, female, white, stage:Stage IIIC, dead, 1229 days
48.5
TCGA-23-1110-01A
0 years, female, white, stage:Stage IIIC, alive, 1658 days
48.4
TCGA-25-1316-01A
0 years, female, white, stage:Stage IIIC, dead, 1279 days
48.1
TCGA-24-2297-01A
0 years, female, white, stage:Stage IIIC, dead, 1699 days
48.0
TCGA-13-2060-01A
0 years, female, white, stage:Stage IV, alive, 2369 days
47.9
TCGA-04-1364-01A
0 years, female, white, stage:Stage IIIC, dead, 1024 days
47.9
TCGA-29-1785-01A
0 years, female, white, stage:Stage IIIC, dead, 1104 days
47.8
TCGA-04-1341-01A
0 years, female, white, stage:'--, alive, 33 days
47.7
TCGA-59-2355-01A
0 years, female, white, stage:Stage IV, dead, 65 days
47.5
TCGA-61-2110-01A
0 years, female, white, stage:Stage IIIC, dead, 1354 days
47.4
TCGA-29-1763-01A
0 years, female, black or african american, stage:Stage IIC, alive, 2032 days
47.3
TCGA-04-1542-01A
0 years, female, white, stage:Stage IIIB, dead, 2561 days
47.1
TCGA-24-1428-01A
0 years, female, white, stage:Stage IIIC, alive, 529 days
47.0
TCGA-24-1430-01A
0 years, female, white, stage:Stage IIIC, dead, 863 days
46.9
TCGA-24-1850-01A
0 years, female, white, stage:Stage IIIC, alive, 168 days
46.6
TCGA-24-1553-01A
0 years, female, white, stage:Stage IIIB, dead, 1767 days
46.2
TCGA-04-1361-01A
0 years, female, white, stage:Stage IIIB, alive, 989 days
46.0
TCGA-29-2414-01A
0 years, female, white, stage:Stage IIIC, dead, 2621 days
45.7
TCGA-24-1552-01A
0 years, female, white, stage:Stage IIIC, dead, 1259 days
45.7
TCGA-61-1728-01A
0 years, female, white, stage:Stage IV, alive, 848 days
45.7
TCGA-13-1404-01A
0 years, female, white, stage:Stage IIIC, alive, 2469 days
45.1
TCGA-61-1919-01A
0 years, female, white, stage:Stage IIIC, dead, 1161 days
45.1
TCGA-30-1860-01A
0 years, female, white, stage:Stage IIIC, dead, 1366 days
45.0
TCGA-61-2092-01A
0 years, female, white, stage:Stage IIIC, alive, 1573 days
44.5
TCGA-13-1489-01A
0 years, female, white, stage:Stage IIIC, dead, 2553 days
44.1
TCGA-30-1862-01A
0 years, female, white, stage:Stage IV, dead, 186 days
43.6
TCGA-04-1648-01A
0 years, female, white, stage:Stage IIIC, dead, 871 days
43.6
TCGA-24-2035-01A
0 years, female, white, stage:Stage IIIC, dead, 857 days
43.3
TCGA-20-1687-01A
0 years, female, white, stage:Stage IV, alive, 81 days
42.7
TCGA-24-2271-01A
0 years, female, asian, stage:Stage IIIC, dead, 962 days
42.5
TCGA-24-1843-01A
0 years, female, white, stage:Stage IIIC, alive, 106 days
42.0
TCGA-04-1356-01A
0 years, female, white, stage:Stage IIC, dead, 1499 days
41.9
TCGA-24-2038-01A
0 years, female, white, stage:Stage IIIA, dead, 1354 days
41.8
TCGA-61-2101-01A
0 years, female, white, stage:Stage IIIC, dead, 1688 days
41.4
TCGA-24-1557-01A
0 years, female, white, stage:Stage IIIC, dead, 1213 days
41.2
TCGA-04-1519-01A
0 years, female, stage:Stage IIIC, alive, 24 days
41.0
TCGA-23-1030-01A
0 years, female, white, stage:Stage IIIC, alive, 886 days
40.7
TCGA-23-1111-01A
0 years, female, white, stage:Stage IIIC, alive, 98 days
40.7
TCGA-36-1568-01A
0 years, female, stage:Stage IIIC, alive, 875 days
40.7
TCGA-61-1910-01A
0 years, female, white, stage:Stage IIC, alive, 1127 days
40.6
TCGA-24-1546-01A
0 years, female, white, stage:Stage IIIC, dead, 1955 days
40.4
TCGA-29-1691-01A
0 years, female, white, stage:Stage IIIC, dead, 1470 days
40.4
TCGA-24-1844-01A
0 years, female, white, stage:Stage IIIC, alive, 113 days
40.1
TCGA-13-1409-01A
0 years, female, white, stage:Stage IIIC, dead, 1742 days
39.9
TCGA-24-0979-01A
0 years, female, white, stage:Stage IV, dead, 1264 days
39.9
TCGA-61-2088-01A
0 years, female, white, stage:Stage IIIC, alive, 145 days
39.5
TCGA-23-1027-01A
0 years, female, white, stage:Stage IIIC, dead, 976 days
39.3
TCGA-24-2281-01A
0 years, female, white, stage:Stage IIA, alive, 1357 days
39.2
TCGA-13-0720-01A
0 years, female, white, stage:Stage IIIC, dead, 1355 days
39.0
TCGA-24-1104-01A
0 years, female, white, stage:Stage IV, dead, 1933 days
39.0
TCGA-13-0920-01A
0 years, female, white, stage:Stage IIIC, dead, 1484 days
38.9
TCGA-13-0730-01A
0 years, female, white, stage:Stage IIIC, dead, 542 days
38.7
TCGA-25-2409-01A
0 years, female, white, stage:Stage IV, dead, 821 days
38.5
TCGA-04-1536-01A
0 years, female, black or african american, stage:Stage IV, dead, 885 days
38.2
TCGA-36-1577-01A
0 years, female, asian, stage:Stage IIC, alive, 783 days
38.0
TCGA-61-1721-01A
0 years, female, white, stage:Stage IV, alive, 338 days
37.1
TCGA-57-1583-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 346 days
37.1
TCGA-09-1669-01A
0 years, female, white, stage:Stage IIIA, alive, 928 days
36.7
TCGA-09-2045-01A
0 years, female, asian, stage:Stage IV, dead, 1069 days
36.3
TCGA-61-1725-01A
0 years, female, white, stage:Stage IIIC, alive, 956 days
36.2
TCGA-13-1501-01A
0 years, female, white, stage:Stage IV, dead, 1314 days
36.1
TCGA-25-1313-01A
0 years, female, white, stage:Stage IV, dead, 820 days
35.4
TCGA-13-1505-01A
0 years, female, white, stage:Stage IIIC, alive, 1998 days
35.3
TCGA-23-1118-01A
0 years, female, white, stage:Stage IIIC, alive, 2616 days
35.1
TCGA-61-1724-01A
0 years, female, white, stage:Stage IIIC, dead, 637 days
35.1
TCGA-24-1416-01A
0 years, female, white, stage:Stage IV, alive, 194 days
35.0
TCGA-04-1655-01A
0 years, female, white, stage:Stage IIIB, dead, 1380 days
34.8
TCGA-24-1544-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 820 days
34.8
TCGA-24-1923-01A
0 years, female, white, stage:Stage IIIC, dead, 690 days
34.2
TCGA-23-1119-01A
0 years, female, white, stage:Stage IIIC, alive, 3953 days
34.2
TCGA-29-1690-01A
0 years, female, white, stage:Stage IIIC, dead, 1448 days
33.9
TCGA-23-1024-01A
0 years, female, white, stage:Stage IV, alive, 468 days
33.9
TCGA-13-1497-01A
0 years, female, white, stage:Stage IIIC, alive, 3871 days
33.8
TCGA-24-1924-01A
0 years, female, white, stage:Stage IIIC, dead, 919 days
33.8
TCGA-23-1109-01A
0 years, female, white, stage:Stage IIIC, dead, 1562 days
33.7
TCGA-30-1718-01A
0 years, female, white, stage:Stage IIIC, dead, 1579 days
33.5
TCGA-23-1116-01A
0 years, female, white, stage:Stage IIIC, dead, 592 days
33.1
TCGA-13-0804-01A
0 years, female, white, stage:Stage IIIC, dead, 1073 days
33.1
TCGA-09-0369-01A
0 years, female, white, stage:Stage IIIC, dead, 1082 days
33.0
TCGA-04-1338-01A
0 years, female, white, stage:Stage IIIC, alive, 1418 days
32.9
TCGA-24-0982-01A
0 years, female, white, stage:Stage IIIC, dead, 679 days
32.5
TCGA-13-1498-01A
0 years, female, white, stage:Stage IIIC, dead, 2012 days
32.1
TCGA-04-1343-01A
0 years, female, white, stage:Stage IV, dead, 361 days
32.0
TCGA-24-1103-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1646 days
31.6
TCGA-13-1499-01A
0 years, female, white, stage:Stage IIIC, alive, 3500 days
31.5
TCGA-24-1845-01A
0 years, female, white, stage:Stage IIIC, alive, 116 days
31.4
TCGA-29-1766-01A
0 years, female, white, stage:Stage IIIC, dead, 1199 days
31.3
TCGA-29-1774-01A
0 years, female, white, stage:Stage IIIC, alive, 527 days
31.0
TCGA-13-1509-01A
0 years, female, white, stage:Stage IV, alive, 2438 days
30.6
TCGA-29-1761-01A
0 years, female, asian, stage:Stage IIIC, dead, 528 days
30.5
TCGA-23-1107-01A
0 years, female, white, stage:Stage IV, dead, 9 days
30.5
TCGA-13-0897-01A
0 years, female, white, stage:Stage IIIC, dead, 2182 days
30.4
TCGA-04-1350-01A
0 years, female, white, stage:Stage IIIC, dead, 1946 days
30.3
TCGA-24-1464-01A
0 years, female, white, stage:Stage IIIC, dead, 379 days
29.6
TCGA-13-0888-01A
0 years, female, white, stage:Stage IIIC, dead, 2811 days
29.6
TCGA-13-0911-01A
0 years, female, white, stage:Stage IV, dead, 1355 days
29.4
TCGA-13-1496-01A
0 years, female, white, stage:Stage IIIC, dead, 129 days
29.4
TCGA-20-0987-01A
0 years, female, white, stage:Stage IIIC, dead, 701 days
29.2
TCGA-61-1738-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1089 days
29.1
TCGA-30-1857-01A
0 years, female, white, stage:Stage IV, dead, 8 days
29.1
TCGA-09-2048-01A
0 years, female, white, stage:Stage IIIC, dead, 138 days
29.0
TCGA-61-1914-01A
0 years, female, stage:Stage IIIC, alive, 1722 days
28.6
TCGA-29-1784-01A
0 years, female, white, stage:Stage IIIC, alive, 163 days
28.6
TCGA-13-1408-01A
0 years, female, white, stage:Stage IIIC, dead, 1680 days
28.2
TCGA-13-1492-01A
0 years, female, white, stage:Stage IIIC, dead, 3819 days
28.0
TCGA-13-1512-01A
0 years, female, white, stage:Stage IIIC, alive, 442 days
27.9
TCGA-20-1686-01A
0 years, female, white, stage:Stage IIIC, alive, 89 days
27.9
TCGA-13-0795-01A
0 years, female, white, stage:Stage IIIC, dead, 619 days
27.9
TCGA-29-2427-01A
0 years, female, white, stage:Stage IIIC, alive, 1900 days
27.6
TCGA-24-1431-01A
0 years, female, white, stage:Stage IIIC, dead, 583 days
27.1
TCGA-23-1023-01A
0 years, female, white, stage:Stage IIIC, alive, 1233 days
27.1
TCGA-13-0885-01A
0 years, female, white, stage:Stage IIIC, alive, 3388 days
27.0
TCGA-13-0923-01A
0 years, female, white, stage:Stage IIIC, alive, 2547 days
27.0
TCGA-24-1471-01A
0 years, female, white, stage:Stage IIIC, alive, 36 days
26.8
TCGA-29-1693-01A
0 years, female, white, stage:Stage IIIC, alive, 3096 days
26.7
TCGA-13-1407-01A
0 years, female, white, stage:Stage IIIC, alive, 2534 days
26.2
TCGA-29-1768-01A
0 years, female, white, stage:Stage IV, dead, 952 days
26.0
TCGA-13-1485-01A
0 years, female, white, stage:Stage IV, dead, 629 days
25.9
TCGA-13-1488-01A
0 years, female, white, stage:Stage IV, dead, 2154 days
25.8
TCGA-20-0991-01A
0 years, female, white, stage:Stage IIB, alive, 797 days
25.6
TCGA-24-1565-01A
0 years, female, white, stage:Stage IIIC, dead, 312 days
25.1
TCGA-13-0887-01A
0 years, female, white, stage:Stage IIIC, dead, 2028 days
24.8
TCGA-13-0762-01A
0 years, female, white, stage:Stage IIIC, alive, 3400 days
24.6
TCGA-04-1332-01A
0 years, female, white, stage:Stage IIIC, dead, 1247 days
24.4
TCGA-13-0891-01A
0 years, female, white, stage:Stage IV, dead, 3128 days
24.1
TCGA-13-0765-01A
0 years, female, white, stage:Stage IIIC, dead, 1389 days
23.9
TCGA-23-1113-01A
0 years, female, white, stage:Stage IV, dead, 949 days
23.5
TCGA-13-0724-01A
0 years, female, white, stage:Stage IV, dead, 83 days
23.4
TCGA-04-1347-01A
0 years, female, white, stage:Stage IV, alive, 1919 days
23.2
TCGA-04-1651-01A
0 years, female, white, stage:Stage IIIC, dead, 1102 days
22.8
TCGA-29-1777-01A
0 years, female, white, stage:Stage IIIC, alive, 374 days
22.3
TCGA-29-1781-01A
0 years, female, white, stage:Stage IIIC, alive, 255 days
21.9
TCGA-30-1853-01A
0 years, female, white, stage:Stage IIIC, dead, 1103 days
21.8
TCGA-10-0927-01A
0 years, female, stage:Stage IIIC, dead, 2490 days
21.5
TCGA-10-0931-01A
0 years, female, white, stage:Stage IIIC, dead, 1000 days
21.5
TCGA-30-1866-01A
0 years, female, white, stage:Stage IV, dead, 1114 days
21.3
TCGA-30-1714-01A
0 years, female, white, stage:Stage IV, dead, 1158 days
21.0
TCGA-13-0726-01A
0 years, female, white, stage:Stage IIIC, dead, 949 days
20.7
TCGA-61-1911-01A
0 years, female, white, stage:Stage IIA, alive, 1293 days
20.7
TCGA-13-0725-01A
0 years, female, white, stage:Stage IIIC, dead, 377 days
20.6
TCGA-13-0714-01A
0 years, female, white, stage:Stage IV, dead, 189 days
20.6
TCGA-29-1769-01A
0 years, female, white, stage:Stage IIIC, alive, 699 days
20.1
TCGA-10-0937-01A
0 years, female, white, stage:Stage IIIC, dead, 608 days
20.1
TCGA-13-1507-01A
0 years, female, white, stage:Stage IIIC, dead, 1993 days
20.1
TCGA-23-1022-01A
0 years, female, white, stage:Stage IIIC, dead, 1511 days
19.9
TCGA-30-1892-01A
0 years, female, white, stage:Stage IIIC, dead, 1484 days
19.5
TCGA-29-1701-01A
0 years, female, white, stage:Stage IIIC, dead, 515 days
19.3
TCGA-29-1696-01A
0 years, female, white, stage:Stage IIIC, dead, 1032 days
19.0
TCGA-09-0367-01A
0 years, female, native hawaiian or other pacific islander, stage:Stage IIIC, dead, 547 days
18.8
TCGA-25-1877-01A
0 years, female, white, stage:Stage IIIC, dead, 730 days
18.6
TCGA-13-0727-01A
0 years, female, white, stage:Stage IIIC, dead, 462 days
16.7
TCGA-13-0766-01A
0 years, female, white, stage:Stage IIIC, dead, 1725 days
15.8
TCGA-13-1477-01A
0 years, female, white, stage:Stage IV, dead, 1662 days
15.3
TCGA-10-0938-01A
0 years, female, white, stage:Stage IIIC, dead, 636 days
14.3
TCGA-24-0966-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 232 days
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
CDV3 is not prognostic in Ovary Serous Cystadenocarcinoma (validation)
Stage:
Survival analysis
Current cut offi
Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.
:
Best expression cut offi
Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .
When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.
Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.
Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.
: N/A
P scorei
Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.
N/A
5-year survival highi
5-year survival for patients with higher expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
5-year survival lowi
5-year survival for patients with lower expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
TCGA RNA samplesi
RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .
Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.
Average TPM
66.5
Number of samples
81
Samples
Sample
Description
TPM
DO46362
0 years, female, NA, stage:III, dead, 1639 days
130.9
DO46336
0 years, female, NA, stage:IV, dead, 664 days
127.2
DO46348
0 years, female, NA, stage:IV, dead, 287 days
116.2
DO46432
0 years, female, NA, stage:III, alive, 2218 days
115.1
DO46374
0 years, female, NA, stage:III, dead, 1409 days
112.7
DO46571
0 years, female, NA, stage:III, dead, 243 days
111.8
DO46588
0 years, female, NA, stage:III, dead, 438 days
110.2
DO46325
0 years, female, NA, stage:III, dead, 477 days
109.2
DO46378
0 years, female, NA, stage:III, alive, 843 days
107.5
DO46606
0 years, female, NA, stage:III, alive, 804 days
97.9
DO46327
0 years, female, NA, stage:III, dead, 184 days
96.8
DO46368
0 years, female, NA, stage:III, dead, 2879 days
96.4
DO46560
0 years, female, NA, stage:IV, dead, 286 days
95.4
DO46388
0 years, female, NA, stage:III, dead, 413 days
94.2
DO46338
0 years, female, NA, stage:III, dead, 596 days
88.0
DO46330
0 years, female, NA, stage:III, dead, 684 days
86.8
DO46398
0 years, female, NA, stage:III, alive, 437 days
85.2
DO46334
0 years, female, NA, stage:III, dead, 496 days
84.4
DO46404
0 years, female, NA, stage:III, dead, 690 days
81.2
DO46332
0 years, female, NA, stage:III, dead, 689 days
80.8
DO46453
0 years, female, NA, stage:III, dead, 3294 days
80.0
DO46346
0 years, female, NA, stage:III, dead, 1187 days
79.5
DO46458
0 years, female, NA, stage:IV, alive, 3787 days
79.0
DO46400
0 years, female, NA, stage:III, dead, 719 days
76.5
DO46561
0 years, female, NA, stage:III, dead, 195 days
75.9
DO46402
0 years, female, NA, stage:III, dead, 511 days
75.8
DO46566
0 years, female, NA, stage:III, dead, 673 days
75.6
DO46382
0 years, female, NA, stage:IV, dead, 311 days
75.2
DO46354
0 years, female, NA, stage:III, dead, 843 days
72.8
DO46508
0 years, female, NA, stage:III, dead, 2101 days
72.7
DO46448
0 years, female, NA, stage:III, dead, 654 days
70.1
DO46586
0 years, female, NA, stage:III, dead, 1019 days
70.0
DO46352
0 years, female, NA, stage:III, dead, 677 days
69.9
DO46518
0 years, female, NA, stage:III, alive, 2960 days
69.6
DO46350
0 years, female, NA, stage:III, dead, 886 days
69.3
DO46597
0 years, female, NA, stage:III, dead, 393 days
67.8
DO46340
0 years, female, NA, stage:III, dead, 616 days
66.7
DO46386
0 years, female, NA, stage:III, dead, 1162 days
65.9
DO46358
0 years, female, NA, stage:III, dead, 423 days
65.5
DO46326
0 years, female, NA, stage:III, dead, 701 days
63.0
DO46443
0 years, female, NA, stage:III, dead, 2464 days
62.8
DO46568
0 years, female, NA, stage:III, dead, 320 days
62.6
DO46384
0 years, female, NA, stage:III, dead, 614 days
61.5
DO46380
0 years, female, NA, stage:III, dead, 1423 days
59.6
DO46396
0 years, female, NA, stage:III, dead, 583 days
57.7
DO46392
0 years, female, NA, stage:III, dead, 628 days
57.1
DO46356
0 years, female, NA, stage:III, dead, 911 days
57.0
DO46591
0 years, female, NA, stage:III, dead, 195 days
56.6
DO46602
0 years, female, NA, stage:III, dead, 205 days
55.5
DO46394
0 years, female, NA, stage:IV, dead, 1039 days
54.9
DO46364
0 years, female, NA, stage:III, dead, 806 days
53.6
DO46533
0 years, female, NA, stage:III, alive, 3667 days
53.3
DO46581
0 years, female, NA, stage:III, dead, 408 days
51.9
DO46513
0 years, female, NA, stage:IV, dead, 1883 days
51.8
DO46493
0 years, female, NA, stage:IV, alive, 839 days
51.7
DO46344
0 years, female, NA, stage:III, dead, 642 days
51.4
DO46342
0 years, female, NA, stage:III, dead, 1398 days
51.4
DO46370
0 years, female, NA, stage:III, dead, 1727 days
50.9
DO46372
0 years, female, NA, stage:III, dead, 1326 days
50.3
DO46436
0 years, female, NA, stage:III, alive, 3193 days
49.7
DO46438
0 years, female, NA, stage:IV, alive, 2227 days
49.3
DO46360
0 years, female, NA, stage:IV, dead, 1759 days
49.0
DO46523
0 years, female, NA, stage:IV, alive, 1873 days
48.5
DO46576
0 years, female, NA, stage:III, alive, 133 days
48.3
DO46551
0 years, female, NA, stage:III, dead, 1055 days
47.8
DO46408
0 years, female, NA, stage:III, dead, 489 days
47.6
DO46463
0 years, female, NA, stage:III, dead, 2451 days
47.6
DO46412
0 years, female, NA, stage:III, dead, 597 days
47.6
DO46468
0 years, female, NA, stage:III, alive, 2776 days
46.0
DO46538
0 years, female, NA, stage:III, dead, 1527 days
44.6
DO46528
0 years, female, NA, stage:III, alive, 6139 days
42.8
DO46611
0 years, female, NA, stage:III, dead, 734 days
39.2
DO46328
0 years, female, NA, stage:III, dead, 972 days
37.7
DO46333
0 years, female, NA, stage:III, dead, 359 days
32.6
DO46546
0 years, female, NA, stage:III, dead, 1889 days
31.7
DO46390
0 years, female, NA, stage:III, dead, 374 days
30.8
DO46329
0 years, female, NA, stage:III, dead, 1699 days
30.1
DO46376
0 years, female, NA, stage:III, dead, 1430 days
29.4
DO46428
0 years, female, NA, stage:IV, alive, 2644 days
24.4
DO46331
0 years, female, NA, stage:III, dead, 612 days
23.0
DO46366
0 years, female, NA, stage:III, dead, 2054 days
21.8
Show allShow less
OVARY SEROUS CYSTADENOCARCINOMA - Protein relative expression (CPTAC)
Number of samples
108
Samples
Sample ID
Sample type
nRPX
1b2ab076-c72f-4bbe-b9f9-657d24_D2
Tumor
1.3
e9d416e7-f661-400a-896e-388545_D2
Tumor
1.2
161317f3-1a39-438e-af45-cd2502_D2
Tumor
1.2
d109a3c0-350e-47f5-bda0-61899c_D2
Tumor
1.1
2563cb02-d58a-4286-8634-7502cd_D2
Tumor
1.1
af95e2c6-25c4-4ab8-bf06-3e15ff_D2
Tumor
1.1
318d53c3-216b-4de1-a098-77d6dd_D2
Tumor
1.1
256ac9f5-1e19-44b4-92fb-fef3fc_D2
Tumor
1.1
76e77c6b-c80e-4391-bdbb-e1dcea_D2
Tumor
1.0
f6c215ea-5381-4521-bb61-be8e97_D2
Tumor
1.0
79b60f32-6cca-4cb6-9a1e-22a3ac_D2
Tumor
1.0
285fed94-1495-448e-879b-b55de9_D2
Tumor
0.9
a8853382-b726-4ce8-98d5-ca89df_D2
Tumor
0.9
bd266bdd-12e4-42cb-9c49-911bfc_D2
Tumor
0.9
6530147a-efe9-4df6-ac2f-03ece3_D2
Tumor
0.9
15524912-685a-47ce-a824-567848_D2
Tumor
0.9
347e379b-77c0-4dd3-aa25-18c9d1_D2
Tumor
0.9
8234f8ea-bdbd-45b0-bd0b-16f1e7_D2
Tumor
0.9
91b287fd-eadb-442d-abcd-20b741_D2
Tumor
0.8
3d3e1888-d67e-4c69-ba83-112d0f_D2
Tumor
0.8
3a380577-c134-47ba-a1ce-988d7c_D2
Tumor
0.7
d38f40fb-dd78-43b2-8b7b-4b6977_D2
Tumor
0.7
51a4ce2f-4166-4c6b-a7e0-942d0a_D2
Tumor
0.7
e7b656bf-3c34-4ba1-bdf3-c7eefe_D2
Tumor
0.7
ce1e5dfc-2ef1-4633-af93-5ea4d9_D2
Tumor
0.7
3946a96c-e0ae-442f-83b4-a9350e_D2
Tumor
0.7
62f5840e-6cd7-4200-b651-645e53_D2
Tumor
0.6
1a10c200-3895-4648-b951-94f99f_D2
Tumor
0.6
9c8e78bf-b03e-4ba0-9909-5ff070_D2
Tumor
0.6
eb0a53df-7620-4024-8d2d-051142_D2
Tumor
0.6
558333b0-ea23-4303-9e3c-4932b1_D2
Tumor
0.6
49bd51fe-48a1-4828-b66e-b30c38_D2
Tumor
0.6
2224c03f-b7b1-4368-887e-2b4cdf_D2
Tumor
0.6
3dcf8b3c-c0c5-4dfa-9543-5d30fb_D2
Tumor
0.6
1de8d3d8-fc0e-4be0-8aa7-127c7b_D2
Tumor
0.5
9b90eb78-2f50-4aeb-b010-d642f9_D2
Tumor
0.5
2dc28da8-7ff1-4b9b-b5bd-17cc25_D2
Tumor
0.5
31c15e30-21d4-4843-bd4a-9cd0d8_D2
Normal
0.4
69d552be-7cb2-4bb4-b602-a27b3e_D2
Tumor
0.4
50997c44-1c8b-4d34-b535-4a6cc2_D2
Tumor
0.4
7c7ce2d7-6c8a-424e-8e6c-d14ad1_D2
Tumor
0.4
fe83e13f-9754-403b-8f74-d6caf8_D2
Tumor
0.4
46c73531-f531-4ec3-97fe-b39d9d_D2
Tumor
0.4
9a7a86d3-bbf2-4d36-941d-c75c03_D1_D2
Tumor
0.4
4ccb249a-6722-491e-97e9-e3b4e7_D2
Tumor
0.4
1556af7e-c2ae-4fce-9aae-87c459_D1_D2
Normal
0.4
52c064a7-78d9-4a1a-85b4-27c6d1_D2
Tumor
0.3
80873a0c-1f40-4d51-bab1-3f2071_D2
Tumor
0.3
7069e990-4a4e-4984-a66d-4d835a_D2
Tumor
0.3
7d953d1d-84b6-4ecd-b1d7-1ed865_D2
Tumor
0.3
9e0d47e0-f633-468b-b82b-4d752d_D2
Tumor
0.3
2433b136-fc7b-4cea-b958-bc6efb_D2
Tumor
0.3
5ea22f5e-307b-491d-801f-8b7fa6_D2
Tumor
0.3
7edfd606-4bee-4529-9fec-1ca7f0_D2
Normal
0.3
092af714-b97a-457c-b0e9-8c20e8_D2
Normal
0.3
1abbcb28-f221-4cd4-8c01-37b9bb_D1_D2
Normal
0.3
2f901c90-617e-46da-9fac-d68369_D2
Tumor
0.2
3fbf076a-824b-4eac-b6dc-bf5e59_D2
Normal
0.2
61f76fe6-a1c6-41b8-bdc2-2f9209_D2
Normal
0.2
340a3769-3031-41ae-bb08-a2f696_D2
Normal
0.2
42d860a3-8a0c-4c44-a09a-9ad8cf_D2
Tumor
0.2
41d0619e-b299-42e2-ac32-29e784_D2
Tumor
0.2
627e6e36-3dca-4ee5-9755-6f3510_D2
Tumor
0.2
2115808b-6a0d-49bc-a8d7-b83bde_D2
Tumor
0.2
e3ebe010-cd31-4b5d-8fcb-b7103b_D2
Tumor
0.2
3490835c-c004-45ed-91f3-7c206f_D2
Tumor
0.2
0cc794c3-5bf5-4621-b238-58a0f6_D2
Tumor
0.2
2b73e01c-347a-4dae-a71d-752aeb_D2
Normal
0.2
10c2d629-0287-4511-ac25-f29031_D2
Tumor
0.2
2b4ce90c-8036-4207-ac3e-54a76f_D2
Tumor
0.1
a03d1103-b809-42c4-ad5c-5aff58_D2
Tumor
0.1
cfd76f9a-ce60-4ec7-8e6b-a8fc31_D3
Tumor
0.1
6319b36b-533c-4e86-8e12-80552e_D3
Tumor
0.1
5c3971ee-87c7-4dff-b66e-f18892_D2
Tumor
0.1
efc971f8-54c5-4531-a792-705ecf_D2
Tumor
0.1
0c87932d-b6fd-4eb5-b86a-a34d07_D2
Tumor
0.1
d4791079-c826-4fc7-9d9b-ee20ba_D2
Tumor
0.0
28d0abdb-f682-4bd3-9425-a9c508_D2
Tumor
0.0
685ec3c2-e67a-40d3-9eb3-aa01c9_D1_D2
Normal
0.0
c17b0ff9-9057-4848-a0cc-abb25f_D2
Tumor
0.0
8d78194e-fbef-4819-a7b5-b73ae9_D2
Tumor
0.0
b9c1f22e-61f7-45ed-b3b4-5094c7_D2
Normal
0.0
fbb41c94-aabd-49cc-90b2-882c3e_D2
Tumor
-0.1
27f3ca2d-a86f-479d-8e7e-5307c7_D2
Tumor
-0.1
927f0958-db5a-4bc5-92b7-2a3695_D2
Tumor
-0.2
994f9b8e-46cb-413f-8ec8-2c2fed_D2
Normal
-0.2
2ed8beb2-bc63-4bad-b5fe-1916a0_D2
Tumor
-0.2
3e746bea-ed68-40e6-b348-6ddf08_D2
Normal
-0.3
1c9145ad-1981-4871-aa7e-8b11de_D2
Tumor
-0.3
08296da7-70ea-44df-8646-09f2cc_D2
Tumor
-0.4
51c1c79e-5a8e-4b0a-bf92-1c0cab_D2
Tumor
-0.4
a583d3ff-8165-43e9-b764-23b7ef_D1_D2
Normal
-0.4
35a345a4-e954-4c81-ae3f-7797cd_D2
Tumor
-0.4
0745488e-0bfb-4d1f-8228-dedf76_D1_D2
Normal
-0.4
6e209757-a7f4-45af-b5f3-2ebc02_D2
Normal
-0.5
74a45e5a-a35a-4c60-a4b4-f3f5ea_D2
Tumor
-0.5
a3a26070-fb84-406a-8280-d555e6_D2
Normal
-0.7
1db5574d-aca7-403c-8100-6e705f_D2
Normal
-0.7
1772e913-f62e-446a-8cf3-720348_D2
Tumor
-0.8
a65d8e76-640f-4341-a561-afbb57_D2
Normal
-0.8
b22659b9-e12c-4725-a7db-a833de_D1_D2
Normal
-0.8
8e17b45e-6a06-4e4e-913d-7b1edb_D2
Tumor
-0.8
21efd60f-6a31-4b98-9477-16a905_D2
Normal
-0.9
8ed739dd-ae0f-4881-971a-db3cf4_D1_D2
Normal
-1.0
eb3f3494-7057-4afe-b212-e6e9a3_D2
Tumor
-1.1
05387aad-2a1f-42c2-8d6f-950598_D3
Tumor
-1.2
e6850782-fd2a-4c53-b682-1852fe_D2
Tumor
-1.3
e23eb014-69c1-460a-b9d4-9786c8_D2
Normal
-1.5
Show allShow less
OVARIAN CANCER - Protein expressioni
A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here.
Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.
Antibody stainingi
Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells.
Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.
The Human Protein Atlas project is funded
